242 related articles for article (PubMed ID: 10351141)
1. Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action.
Lazarus AH; Freedman J; Semple JW
Transfus Sci; 1998 Sep; 19(3):289-94. PubMed ID: 10351141
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of IVIG and anti-D in ITP.
Lazarus AH; Crow AR
Transfus Apher Sci; 2003 Jun; 28(3):249-55. PubMed ID: 12725951
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
Blanchette V; Carcao M
Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
[TBL] [Abstract][Full Text] [Related]
4. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.
Crow AR; Lazarus AH
J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S14-8. PubMed ID: 14668633
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg).
Imbach P; Morell A
Int Rev Immunol; 1989; 5(2):181-8. PubMed ID: 8691051
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of IVIG action in immune thrombocytopenic purpura.
Hansen RJ; Balthasar JP
Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
[TBL] [Abstract][Full Text] [Related]
7. Treatment of immune thrombocytopenic purpura in children : current concepts.
Shad AT; Gonzalez CE; Sandler SG
Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
[TBL] [Abstract][Full Text] [Related]
8. Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.
Cooper N; Heddle NM; Haas M; Reid ME; Lesser ML; Fleit HB; Woloski BM; Bussel JB
Br J Haematol; 2004 Feb; 124(4):511-8. PubMed ID: 14984503
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
Song S; Crow AR; Freedman J; Lazarus AH
Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
[TBL] [Abstract][Full Text] [Related]
10. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
Mehta YS; Badakere SS
J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte subsets in patients with idiopathic thrombocytopenic purpura during high-dose gamma globulin therapy.
Pogliani EM; Della Volpe A; Casaroli I; Maffe PF; Corneo G
Allergol Immunopathol (Madr); 1991; 19(3):113-6. PubMed ID: 1799168
[TBL] [Abstract][Full Text] [Related]
12. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
Crow AR; Song S; Siragam V; Lazarus AH
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
[TBL] [Abstract][Full Text] [Related]
14. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
15. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
Cooper N
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1317-27. PubMed ID: 19932436
[TBL] [Abstract][Full Text] [Related]
17. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study.
Peng J; Ma SH; Liu J; Hou Y; Liu XM; Niu T; Xu RR; Guo CS; Wang XM; Cheng YF; Ni H; Hou M
J Thromb Haemost; 2014 Apr; 12(4):497-504. PubMed ID: 24517219
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
[TBL] [Abstract][Full Text] [Related]
19. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
Bazin R; Lemieux R; Tremblay T; St-Amour I
Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
[TBL] [Abstract][Full Text] [Related]
20. Harmful and beneficial antibodies in immune thrombocytopenic purpura.
Imbach PA
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):25-30. PubMed ID: 8033430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
